Comorbidities: Type 2 diabetes: Both are FDA-approved for diabetes (tirzepatide as Mounjaro, semaglutide as Ozempic) Cardiovascular disease: Semaglutide has the cardiovascular outcomes data Sleep apnea: Tirzepatide has shown benefits Injection frequency: Both are once-weekly
It depends entirely on how long you stay at microdoses versus how quickly you reach standard therapeutic levels
Medications come in a 1-month or 2-months supply
Syringes are seen as med gear & may have set laws based on where you live
At Chicago Arthritis and Regenerative Medicine, we are committed to staying at the forefront of these advancements, ensuring patients receive the most effective and innovative treatments available
Along with research, prioritizing equity across the therapeutic continuum, from drug development and trials to prescription drug payment policy and clinical practice, will ensure that all patients receive the highest quality of medication care in the Veterans Health Administration and beyond. Reference: Essien UR, et al